|  | Men | Women | ||
---|---|---|---|---|---|
 |  | HR* (95% CIs) | P-value | HR* (95% CIs) | P-value |
CVD | Global CVD risk†<20% | 1.07 (0.80-1.42) | 0.643 | 1.46 (1.05-2.03) | 0.025 |
 | Global CVD risk†≥20% | 1.09 (0.90-1.32) | 0.374 | 1.20 (0.75-1.92) | 0.440 |
All-cause mortality | Global CVD risk†<20% | 0.75 (0.52-1.08) | 0.128 | 0.74 (0.48-1.15) | 0.183 |
 | Global CVD risk†≥20% | 0.80 (0.62-1.01) | 0.064 | 1.17 (0.54-2.57) | 0.688 |
CVD | Assigned to the intervention | 1.58 (1.11-2.26) | 0.011 | 1.43 (0.89-2.29) | 0.143 |
 | Not assigned to the intervention | 1.01 (0.82-0.1.25) | 0.896 | 1.33 (0.90-1.96) | 0.148 |
All-cause mortality | Assigned to the intervention | 0.71 (0.49-1.02) | 0.061 | 1.16 (0.62-2.15) | 0.641 |
 | Not assigned to the intervention | 0.77 (0.61-0.98) | 0.034 | 0.73 (0.44-1.20) | 0.214 |